Completed

Phase 3
Age: 18Years - 75Years
MALE
ID00000582

Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2012-04-27

N/A

Participants Needed

N/A

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

To test the efficacy of prothrombin complex concentrates (Factor IX) in the treatment of hemophiliac patients who had inhibitors to Factor VIII.

CONDITIONS

Official Title

Cooperative Study of Factor VIII Inhibitors

Who Can Participate

Age: 18Years - 75Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

Males with hemophilia, not stratified as to ethnic group.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Site Locations not provided

Location information for this trial is currently unavailable.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

N/A

Model

N/A

Primary Purpose

TREATMENT

Number of Arms

0

Similar Trials

Study Comparing NXT007 and Emicizumab Prophylaxis in People ...

Hemophilia A

Actively Recruiting

6 locations

Study to Compare NXT007 and Factor VIII Prophylaxis in Peopl...

Hemophilia A

Actively Recruiting

2 locations

An Open-Label Study of Weekly Marstacimab Injections for Ped...

Hemophilia A

Actively Recruiting

34 locations

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.

J M Lusher, S S Shapiro, J E Palascak...

https://pubmed.ncbi.nlm.nih.gov/6771653